Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Including androgens in hormone therapy may lower breast cancer risk.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

Anabolic steroids and SARMs can cause serious liver damage.

SARMs may offer benefits by boosting muscle effects without unwanted side effects.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Muscles can make their own androgens, which may help muscle growth.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

SARMs work differently in tissues due to unique interactions and structures.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Minoxidil can cause skin allergy; use alternative solvents or treatments if allergic.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

New treatments for male hypogonadism are effective and should be personalized.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.